Following a pre-specified interim analysis, the Data Safety Monitoring Board (DSMB) recommended the DRAGON trial, a pivotal Phase 3 trial in ...

Generation Bio Co. (GBIO) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.53 per share a year ago. These figures ...

Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases- Lead target ...

ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Thursday reported a loss of $51.2 million in its fourth quarter. On a per-share basis, the Rockville, Maryland-based company said ...

Onego Bio, a food ingredient company producing egg protein powder through fermentation, will become the second tenant at Jefferson County’s Food and Beverage Innovation Campus. The $777,000 purchase ...

The company sees revenue in the range of $3.0 billion to $3.1 billion for the full year 2025. Analysts, on average, estimate revenue of $2.92 billion for the same period. The company projects ...

The commercial-stage biotechnology company posted revenue of $73.7 million for the quarter, missing the consensus estimate of $77. ... For the full year 2024, Iovance reported total product ...

We maintain our $130 fair value estimate for wide ... beyond calendar 2025. Revenue in the January quarter was $39.3 billion, up 12% sequentially, up 78% year over year, and ahead of guidance ...

The company forecasted revenue in the range of $165 million to $175 million, whereas the consensus estimate was $186.9 ... development earlier in the year. On January 13, Illumina Inc (NASDAQ ...

Operating income decreased by 11.4% to €2.6 million from € ... no obligation to update or revise the information contained in this press release. Estimated Full-Year 2024 Consolidated Financial ...

Revenue fell 17% year-over-year to 156.9 billion euros but topped expectations. Shipment volumes fell 12% due to "temporary gaps in product offerings, as well as now-complete inventory reduction ...

For the quarter, the company's total revenue amounted to $667.5 million, experiencing a decline of 2% year over year. Next, we'll explore the breakdown of BIO's international revenue to understand the ...